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Abstract
Background: Tuberculosis (TB) is a major cause of childhood morbidity and mortality in developing countries. One
of the main difficulties is obtaining adequate specimens for bacteriological confirmation of the disease in children.
The aim of this study is to evaluate the adequacy of fine-needle aspiration (FNA) for the diagnosis of TB.
Methods: In a prospective study conducted at the paediatric hospital in Bangui in 2007–2009, we used fine-needle
aspiration to obtain samples for diagnosis of TB from 131 children aged 0–17 years with persistent lymphadenitis.
Results: Fine-needle aspiration provided samples that could be used for bacteriological confirmation of TB.
Ziehl-Neelsen staining for acid-fast bacilli was positive in 42.7% of samples, and culture identified TB in 67.2% of
cases. Of 75 samples that were stain-negative, 49 (65.3%) were culture-positive, while 12 stain-positive samples
remained culture-negative. Ten of the 12 stain-positive, culture-negative samples were from patients who had
received previous antimicrobial therapy. With regard to phenotypic drug susceptibility, 81/88 strains (91.1%) were
fully susceptible to isoniazid, rifampicin, ethambutol and streptomycin, six (6.8%) were resistant to one drug, and
one multidrug-resistant strain was found.
Conclusions: Fine-needle aspiration is simple, cost-effective and non-invasive and can be performed by trained
staff. Combined with rapid molecular diagnostic tests, fine-needle aspirates could improve the diagnosis of TB and
provide valuable information for appropriate treatment and drug resistance.
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Background
Tuberculosis (TB) is a major cause of childhood morbid-
ity and mortality in developing countries ([1,2]. Accurate
figures on the prevalence of paediatric TB are not avail-
able because the health information systems in endemic
countries are inadequate and limited attention is paid to
children, who contribute little to TB transmission in
affected communities. The World Health Organization
(WHO) estimates of TB incidence are based on sputum
smear-positive cases, but more than 80% of children
with TB are sputum smear-negative, and extrapulmonary
TB is common in these patients. According to WHO,
the evaluation of new techniques to improve the diag-
nosis and management of paediatric TB is an urgent
research priority [3].
Like most sub-Saharan countries, the Central African
Republic (CAR) pays a heavy price in terms of TB mor-
bidity and mortality, with an annual incidence of all
forms of TB estimated in 2009 at 345 per 100 000 [4]
and a death rate of 113 per 100 000 inhabitants [5]. The
situation is aggravated by co-infection with HIV, also in
children: in a study conducted in 2005 [6], 25.7% of chil-
dren aged 18 months to 15 years being treated for TB in
the paediatric clinic in Bangui were co-infected with
HIV. In the same study, fine-needle aspirates showed
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Tuberculous lymphadenopathy is a common cause of
peripheral adenopathy among children [7], and lymph-
adenopathy is a common clinical symptom of extrapul-
monary TB in the pediatric age group, responsible for
up to 50% of all extrathoracic TB [8,9]. In endemic areas,
TB is the commonest cause (22–48%) of persistent cer-
vical lymphadenopathy [10].
Fine-needle aspiration is a simple, safe outpatient
procedure that can be performed by nurses in resource-
limited settings. It provides material for direct micros-
copy, culture and susceptibility testing, thus improving
bacteriological diagnosis [11]. It nevertheless remains a
greatly underused means of collecting specimens and
has not been used systematically in CAR.
The objective of this study was to evaluate the
adequacy of fine-needle aspirates from enlarged




A prospective study was conducted between 2007 and
2009 at Unit D of the Paediatric Hospital of Bangui. The
main inclusion criterion was the presence of adenitis.
Thus, all children aged 0–17 years who had had lymph-
adenitis of unknown etiology for over 1 month were
included. Lymphadenitis was defined as a painless firm
or soft swelling in a group of superficial lymph nodes
[12]. Parents or guardians gave their written informed
consent for study participation. Ethical approval was
obtained from the ethics committee of the CAR.
Tuberculin skin testing was performed in several chil-
dren; however, because some children had been vacci-
nated and the HIV serological status of all the children
was not known, we could not take into account the par-
tial data obtained from skin testing.
Sampling
In general, parents or guardians held the child during
the procedure. Fine-needle aspiration was performed by
a paediatric doctor using an 18-G needle (1.2 x 40 mm),
who fixed the enlarged lymph node and inserted the
needle in various directions. A different needle was used
for each affected node, with a maximum of two per
patient. The needle and syringe were immediately
sent to the Institut Pasteur of Bangui for Ziehl-Neelsen
staining for detection of acid-fast bacilli by optical
microscopy, culture on Löwenstein-Jensen medium to
identify Mycobacterium tuberculosis and testing for drug
susceptibility.
Identification and drug-susceptibility testing
M. tuberculosis was identified on the basis of biochem-
ical and morphological criteria: growth rate, colony
morphology, resistance to 2 mg/ml hydrazide acid
thiophene-2 carboxylic acid, sensitivity to 0.5 mg/ml
para-aminosalicylate and 10 mg/ml thiosemicarbazone,
niacin production, nitrate reduction and catalase
production. Susceptibility to anti-TB drugs was deter-
mined by the indirect proportion method [13] from
the critical concentrations of isoniazid (0.2 μg/ml),
rifampicin (40 μg/ml), ethambutol (2 μg/ml) and
streptomycin (4 μg/ml).
Results
Of 131 children who presented with suspected tubercu-
lous lymphadenitis, nearly half (45.8%) were aged 0–5
years, and 69 (53%) had known contact with active TB
within the family. All the children had general symptoms
including fever (92%), asthenia (61%) and weight loss
(88%). Most of the children (76%) presented with
enlarged posterior cervical lymph nodes; the other loca-
tions were axillary (50%), inguinal (46%) and subman-
dibular (32%) (Table 1); 97 (74%) children showed
swelling of multiple nodes. HIV serology was performed
in 103 children, and 36 (35%) were found to be seroposi-
tive, 63 (61%) seronegative and 4 (4%) of unclear HIV
status.
Fine-needle aspiration was performed on one or two
enlarged lymph nodes from each child. Ziehl-Neelsen
staining was positive for 56/131 (42.7%) cases (Table 2);
of these, 49.5% patients presented multiple enlarged
nodes and 23.5% a single node. Of the Löwenstein-
Jensen cultures, 88 (67.2%) were positive, 41 were
Table 1 Demographics and sample charactereristics of
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negative and two were discarded because of contamin-
ation. Of 75 samples that were negative for acid-fast
bacilli, 49 (65.3%) were positive by culture, while 12
stain-positive samples remained culture-negative.
Previous treatment of the patients was determined
from clinical data. Ten of the 12 stain-positive samples
with a negative Löwenstein-Jensen culture were from
patients who had received antimicrobial therapy before
fine-needle aspiration. All 88 positive cultures were
identified as belonging to the M. tuberculosis complex.
No nontuberculous mycobacteria were identified. With
regard to phenotypic drug susceptibility, 81/88 strains
(91.1%) were fully susceptible to isoniazid, rifampicin,
ethambutol and streptomycin, six (6.8%) were resistant
to one drug, and one multidrug-resistant strain was
found (Table 3). The child (11 years) with a phenotypic
multidrug-resistant strain had a history of prior TB
treatment.
More bacteriologically confirmed TB cases were found
among HIV-seronegative (45/63, 71%) than HIV-
seropositive children (Table 4).
Discussion
This study confirms the usefulness of fine-needle aspir-
ation for investigating patients with suspected tubercu-
lous lymphadenitis before starting anti-TB therapy.
Microscopy showed the presence of potential TB bacilli
in 42.7% of the aspirates, and culture identified TB in
67.2% of cases. The percentage of Ziehl-Neelsen-positive
strains was much higher than the 18% observed by Knox
[14] but close to those reported recently (45% [15] and
48.2–51.8% [16]) with light-emitting diode microscopy
in studies of mycobacterial lymphadenitis in fine-needle
aspirates from children. The conventional Ziehl-Neelsen
method on smears is widely used and plays a key role in
TB diagnosis, but it has a poor sensitivity in aspirates
because of the small number of mycobacterial cells.
Löwenstein-Jensen culture showed that 88 (67.2%) sam-
ples were positive, confirming the greater sensitivity of
culture than Ziehl-Neelsen staining, and in agreement
with recent reports of culture sensitivity of 65.8% [15],
69% [16] and 86.4% [14].
Our finding that 83.3% of smear-positive culture-
negative specimens were from patients who had received
anti-TB treatment suggests that positive acid-fast bacilli
results might correspond to dead bacilli from previously
treated patients. This confirms the need to perform bac-
teriological diagnosis before treatment. Mycobacterial
culture is the gold standard for detecting tubercle bacilli,
although it is time-consuming and requires specialized
technology and procedures in a biosafety facility.
The study confirmed that the overall drug resistance
rate is close to that reported in CAR between 1998
and 2000 [6] and is lower than the rate published by
Koeck et al. [17] in Djibouti. Resistance to isoniazid and
streptomycin was most frequent in children with undiag-
nosed TB, which confirms our previous findings in
adults [18]. In CAR, these drugs are improperly used for
the treatment of other bacterial infections, which can
lead to resistance.
In general, biopsy is the preferred method for obtain-
ing a sample for testing. In most of sub-Saharan Africa,
however, due to a lack of facilities and manpower, it is
feasible for only very few patients. Lymph node aspirates
are simple to obtain, and the procedure is cheap and safe
with limited risks, as it is less invasive and requires min-
imal instrumentation. This technique is especially suit-
able for peripheral lymph nodes and can be performed
by trained nurses in small hospitals and clinics.
Recent advances in molecular diagnosis will affect
future TB diagnostic approaches. Detection of mycobac-
terial DNA and rifampicin resistance with nucleic
acid-based methods can be helpful in the diagnosis of
tuberculous lymphadenatis. Combining fine-needle as-
piration, which can be performed on an outpatient basis
in a primary health care setting, with a rapid, sensitive
diagnostic technique such as those based on nucleic
acids may contribute substantially to the effective
Table 3 Drug-susceptibility results for 88 M. tuberculosis-
complex isolated from 131 children with tuberculous
lymphadenitis
Resistance profile N (%)
Susceptible to all drugs 81 (91.1)
Resistant to INH only 3 (3.4)
Resistant to SM only 3 (3.4)
MDR 1 (1.1)
Total 88
Table 2 Outcome of bacteriological diagnosis for FNA










Positive 39 17 56
Negative 49 24 73
Total 88 41 129*
*2 strains were contaminated.






Culture-positive 18/63 (29%) 45/63 (71%) 0.0055
Culture-negative 18/36 (50%) 18/36 (50%)
Fanny et al. BMC Pediatrics 2012, 12:191 Page 3 of 4
http://www.biomedcentral.com/1471-2431/12/191
management of mycobacterial infection in children
[19,20]. The implications of rapid, accurate diagnosis in-
clude access to appropriate, adequate therapy and less
costly further investigations. The fully automated real-
time polymerase chain reaction-based GeneXpert MTB/
RIF test allows rapid, highly sensitive detection of M. tu-
berculosis complex DNA and of mutation-mediating ri-
fampicin resistance [21], and WHO recently endorsed
this new diagnostic test [22]. When used on lymph node
tissue, the reported sensitivity for bacterial diagnosis was
86% [19] to 96% [20]. This new test and other, more ef-
fective, less costly tests being developed will strengthen
rapid diagnosis from fine-needle aspirates. Rational
use of fine-needle aspiration followed by immediate
empiric therapy is the optimal approach. Although the
GeneXpert MTB/RIF test may be useful for rapid detec-
tion of TB in lymph node aspirates and can indicate
multidrug-resistant TB in cases of rifampicin resistance,
it cannot, however, replace other tests for precise identi-
fication of other antibiotic resistance or confirm rifampi-
cin resistance.
Conclusions
The use of fine-needle aspiration, combined with new,
rapid molecular diagnostic tests, could improve the
diagnosis of tuberculous lymphadenopathy and provide
valuable information for appropriate treatment. In this
study, we were unable to assess complications such as
haemorrhage, secondary infection or the development of
sinuses, and these aspects should be considered in fur-
ther studies to ensure that the procedure is safe and to
define the rate of complications.
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